CARCINOMA IN SITU

This adverse event was reported 167 times

These drugs are most commonly taken by patients reporting CARCINOMA IN SITU:

# Drug Count
0 ADALIMUMAB 17
1 PREDNISONE 16
2 ADALIMUMAB-AATY 12
3 ADALIMUMAB-ADAZ 12
4 ADALIMUMAB-FKJP 12
5 INFLIXIMAB 11
6 METHOTREXATE SODIUM 11
7 AZATHIOPRINE 10
8 FINGOLIMOD HCL 10
9 METHOTREXATE 10
See all common drugs associated with CARCINOMA IN SITU